Core Viewpoint - Universal Health Services (UHS) shares have increased by 2.4% recently, closing at $178.74, with a potential upside of 26.3% based on Wall Street analysts' mean price target of $225.81 [1] Price Targets - The average of 16 short-term price targets ranges from a low of $198 to a high of $280, with a standard deviation of $21.94, indicating variability among analysts [2] - The lowest estimate suggests a 10.8% increase from the current price, while the highest estimate indicates a 56.7% upside [2] Analyst Sentiment - Analysts show a consensus that UHS will report better earnings than previously estimated, which historically correlates with stock price increases [4][11] - Over the last 30 days, the Zacks Consensus Estimate for the current year has risen by 0.3%, with four estimates moving higher and one lower [12] Zacks Rank - UHS holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimate factors, suggesting a strong potential for upside [13]

Core Viewpoint - Shift4 Payments (FOUR) has seen a 13.6% increase in share price over the past four weeks, closing at $82.36, with a potential upside of 41.2% based on Wall Street analysts' mean price target of $116.29 [1] Price Targets - The average of 24 short-term price targets ranges from a low of $80 to a high of $150, with a standard deviation of $16.01, indicating variability among analysts [2] - The lowest estimate suggests a decline of 2.9% from the current price, while the highest estimate indicates an upside of 82.1% [2] Analyst Sentiment - Analysts show a consensus that FOUR will report better earnings than previously estimated, which supports the expectation of a stock price increase [4][11] - Over the last 30 days, the Zacks Consensus Estimate for the current year has increased by 17.3%, with seven estimates moving higher and one lower [12] Zacks Rank - FOUR holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimate factors, indicating strong potential for upside [13]

Shares of Archrock Inc. (AROC) have gained 12.7% over the past four weeks to close the last trading session at $24.56, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going by the price targets, the mean estimate of $31.13 indicates a potential upside of 26.8%.The average comprises eight short-term price targets ranging from a low of $29 to a high of $33, with a standard deviation of $1.25. While the lowest estimate indicates ...

FTAI Aviation (FTAI) closed the last trading session at $89.95, gaining 1.9% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of $173.92 indicates a 93.4% upside potential.The mean estimate comprises 12 short-term price targets with a standard deviation of $46.31. While the lowest estimate of $123 indicates a 36.7% increase from the current price level, the most optimistic analyst expe ...

Core Viewpoint - Alibaba (BABA) has shown a 7.9% increase in stock price over the past four weeks, with a mean price target of $158.20 indicating a potential upside of 25.8% from the current price of $125.76 [1] Price Targets and Estimates - The mean estimate consists of 20 short-term price targets with a standard deviation of $20.48, where the lowest estimate is $112 (10.9% decline) and the highest is $190 (51.1% increase) [2] - A low standard deviation among price targets suggests a high degree of agreement among analysts regarding the stock's price movement [9] Analyst Sentiment and Earnings Estimates - Analysts show strong agreement in revising earnings per share (EPS) estimates higher, which correlates with potential stock price increases [11] - The Zacks Consensus Estimate for the current year has increased by 1.2% over the past month, indicating positive sentiment [12] - BABA holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimates [13] Caution on Price Targets - Price targets can mislead investors, as empirical research indicates they rarely predict actual stock price movements [7] - Analysts may set overly optimistic price targets due to business incentives, which can inflate expectations [8] - While price targets should not be ignored, they should be approached with skepticism and not be the sole basis for investment decisions [10]

Shares of Euroseas Ltd. (ESEA) have gained 18.9% over the past four weeks to close the last trading session at $32.34, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going by the price targets, the mean estimate of $53.67 indicates a potential upside of 66%.The mean estimate comprises three short-term price targets with a standard deviation of $8.50. While the lowest estimate of $44 indicates a 36.1% increase from the current ...

LifeStance Health Group (LFST) closed the last trading session at $6.80, gaining 2.4% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of $8.75 indicates a 28.7% upside potential.The average comprises eight short-term price targets ranging from a low of $7 to a high of $10, with a standard deviation of $1.07. While the lowest estimate indicates an increase of 2.9% from the current pric ...

Shares of Iridium Communications (IRDM) have gained 2.4% over the past four weeks to close the last trading session at $25.17, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going by the price targets, the mean estimate of $38.33 indicates a potential upside of 52.3%.The mean estimate comprises six short-term price targets with a standard deviation of $7.23. While the lowest estimate of $25 indicates a 0.7% decline from the c ...

Group 1 - Oatly Group AB (OTLY) closed at $10.74, with a 20.5% gain over the past four weeks, and a mean price target of $18.31 indicating a 70.5% upside potential [1] - The mean estimate includes seven short-term price targets with a standard deviation of $10.72, ranging from a low of $10 (6.9% decline) to a high of $40 (272.4% increase) [2] - Analysts show strong agreement in revising earnings estimates higher, with a 10.3% increase in the Zacks Consensus Estimate for the current year, indicating potential upside for the stock [11][12] Group 2 - The consensus price target is not the sole factor for investment decisions, as analysts' ability to set unbiased price targets has been questioned [3][7] - Analysts often set overly optimistic price targets due to business incentives, which can lead to inflated expectations [8] - A low standard deviation in price targets suggests a high degree of agreement among analysts regarding the stock's price movement, serving as a starting point for further research [9]

Core Viewpoint - There is significant upside potential for Veren (VRN) stock, with a mean price target of $7.99 indicating a 35% increase from the current price of $5.92 [1] Price Targets and Analyst Consensus - The average of 10 short-term price targets ranges from a low of $6.60 to a high of $9.75, with a standard deviation of $1.09, suggesting variability in analyst estimates [2] - The lowest estimate indicates an 11.5% increase, while the highest suggests a 64.7% upside [2] - A low standard deviation indicates a high degree of agreement among analysts regarding the stock's price movement [9] Earnings Estimates and Market Sentiment - Analysts have shown increasing optimism about VRN's earnings prospects, as evidenced by a strong agreement in revising EPS estimates higher [11] - Over the last 30 days, the Zacks Consensus Estimate for the current year has increased by 1.4%, with one estimate moving higher and no negative revisions [12] - VRN holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimates [13] Caution on Price Targets - Solely relying on consensus price targets for investment decisions may not be wise, as analysts' ability to set unbiased targets has been questioned [3][7] - Analysts often set overly optimistic price targets due to business incentives, which can lead to inflated estimates [8] - While price targets should not be ignored, they should be treated with skepticism and not be the sole basis for investment decisions [10]